Page 0095

TREATMENT

growing number of new cancer patients, it would be desirable in LMIC, radiotherapy and palliative care services should be

to utilize initiatives such as AGaRT to press for megavoltage planned at the national level as an integrated component of a

machines which do not require frequent calibration and national cancer control programme with careful long-term

dosimetry measurements or perhaps the on-site presence of a infrastructure and workforce planning within the scope of

medical physicist (thus optimising the time of any physicist targets defined to implement the resolution on NCDs.

available). This could also have a significant impact on the mix The relative success of recent international efforts such as

of staff required for running a radiotherapy clinic effectively IAEA’s PACT partnership, its AGaRT and VUCCnet initiatives,

and safely. and the Joint Programme with WHO are encouraging. No

There has already been a response to the AGaRT initiative doubt such collective efforts, if maintained and strengthened

with some radiotherapy manufacturers developing new with support from the industry, can play a major role in making

systems that consist of megavoltage units (4–6 MeV linacs) radiotherapy technology accessible and affordable to cancer

and include several basic capabilities and software to provide patients all over the world, regardless of their location or

for an integrated treatment system. These systems also financial means. l

include a warranty and training to educate operators on

system use. It is hoped that more initiatives like these will Massoud Samiei, PhD, MSc, MBA, DIC has extensive planning

continue to develop and be tailored to provide for the and management experience in the application of nuclear

individual needs of regions and health systems. technology for development, particularly nuclear power, fuel

cycle, research reactors, and radiation health technologies. He

Conclusions started his professional career in Mexico’s Nuclear Research

The current situation in most LMIC with an average of less Centre in 1980. During 1983–89 he worked for a number of

than 30% of all cancer patients having access to any services is international nuclear energy development projects. In 1989, he

totally unacceptable. There is a lot that the international joined the IAEA’s Department of Technical Cooperation (TC)

community can do by supporting global partnerships and joint with responsibilities for countries in Eastern Europe and the

programmes among the various active key players. To meet the Middle East. He was head of the IAEA TC’s Europe Region from

needs of the growing number of cancer patients a complete 1993 to 2005. In this capacity he was responsible for the

solution will need to be developed that can address all facets formulation of assistance programmes for some 30 states in

of radiotherapy acquisition and use, assisting the ever- Europe and the former Soviet Union, and for shaping up the

growing number of patients in LMIC to access the IAEA’s human health, environmental remediation, nuclear

radiotherapy treatment that they require. More affordable safety, nuclear power, research reactor and nuclear security

solutions to the cancer epidemic are urgently required as with related assistance to this region. In February 2005, Massoud

each passing day the number of those afflicted with the Samiei was appointed as Programme Director of IAEA’s

disease climbs and the global impact of cancer continues to Programme of Action for Cancer Therapy (PACT) and Head of

grow. Radiation therapy is an essential component of cancer the PACT Programme Office, a post he held untill 31 May 2012.

treatment and must be made available to all who need it. He brought broad international experience and knowledge in

The encouraging news is the high level resolution adopted in development, resource mobilization, education and training and

September 2011 by the United Nations’ General Assembly on health-related nuclear technology assistance to PACT. Through

Prevention and Control of Noncommunicable Diseases innovative partnerships with WHO and other international

(NCDs) following the leadership and extensive efforts of organizations, educational and research institutions and the

WHO, supported by other UN agencies and a significant private sector, PACT has moved the IAEA’s cancer-related

number of NGOs. This is the first time that the global programmes to a public health model where its radiotherapy

community has recognized at the highest international forum, intervention is being integrated into national cancer control

with strong support of all countries, the burden of NCDs, plans to maximize the public health impact of treatment

including cancer, and their serious social and economic impact investments. By end 2011, PACT had mobilized over US$30

in LMIC. The implementation of this resolution, as requested million from nongovernmental donors to assist developing

by the General Assembly, will open the way for the donor countries to expand their cancer control and care capacity.

community to look at successful programmes and Massoud Samiei is currently an independent international

interventions that can offer suitable and sustainable solutions expert collaborating with the IAEA, WHO, IARC, UICC, Oxford

for developing countries. In this context, to ensure the University and INCTR, among others.

development of effective and sustainable treatment capacity

CANCER CONTROL 2013 93

Index

  1. CANCER CONTROL 2013
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122
  123. Page 0123
  124. Page 0124
  125. Page 0125
  126. Page 0126
  127. Page 0127
  128. Page 0128
  129. Page 0129
  130. Page 0130
  131. Page 0131
  132. Page 0132
  133. Page 0133
  134. Page 0134
  135. Page 0135
  136. Page 0136
  137. Page 0137
  138. Page 0138
  139. Page 0139
  140. Page 0140
  141. Page 0141
  142. Page 0142
  143. Page 0143
  144. Page 0144
  145. Page 0145
  146. Page 0146
  147. Page 0147
  148. Page 0148
  149. Page 0149
  150. Page 0150
  151. Page 0151
  152. Page 0152
  153. Page 0153
  154. Page 0154
  155. Page 0155
  156. Page 0156
  157. Page 0157
  158. Page 0158
  159. Page 0159
  160. Page 0160
  161. Page 0161
  162. Page 0162
  163. Page 0163
  164. Page 0164
  165. Page 0165
  166. Page 0166
  167. Page 0167
  168. Page 0168
  169. Page 0169
  170. Page 0170
  171. Page 0171
  172. Page 0172
  173. Page 0173
  174. Page 0174
  175. Page 0175
  176. Page 0176
  177. Page 0177
  178. Page 0178
  179. Page 0179
  180. Page 0180

powered by PageTiger